A Curated Platform of Equity & Options Market Intelligence
Select Page

DVAX

Search by
TICKER SYMBOL

Dynavax Technologies Corp.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

12.41

0

(0%)

Volume:

1,531,391

52 week range:

9.48 - 15.15

Market Cap:

1.605B

Company Description:

dynavax technologies corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. our clinical-stage product candidates include: phase 3 heplisav-b ™ adult hepatitis b vaccine phase 1/2 cancer immunotherapy phase 2 asthma therapy - partnered with astrazeneca in europe, dynavax manufactures hepatitis b surface antigen for heplisav-b.